Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs Steroid in Children With New-onset Nephrotic Syndrome
NCT05734794Phase 3Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Feb 2023
- Primary completion
- Dec 2025
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in nephrotic syndrome, sponsored by Children's Hospital, Zhejiang University School of Medicine. Started Feb 2023; status: recruiting.
02
Drugs
rituximab
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT05734794.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05734794.